Finance

Lists
CYV:ASX
Ceryvyn Therapeutics Ltd
A$0.011
0.00%
(0.00) 1D
Sep 10, 4:10:06 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CYV...
Mkt. cap
15.05M
Avg. vol.
4.88M
Volume
0.00
P/E ratio
0.04
52-wk high
A$0.01
52-wk low
A$0.01
EPS
A$0.24
Shares outstanding
1.37B
No. of employees
33
Mkt. cap
15.05M
Avg. vol.
4.88M
Volume
0.00
P/E ratio
0.04
52-wk high
A$0.01
52-wk low
A$0.01
EPS
A$0.24
Shares outstanding
1.37B
No. of employees
33
News stories
From web sources and news partners
About Ceryvyn Therapeutics Ltd
CEOEde
Employees33
Founded1984
Headquarters-
SectorBiotechnology
Websiteceryvyn.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
500.00
500.00
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
628.50K
628.50K
446.50K
446.50K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.90M
2.90M
1.91M
1.91M
Operating expense
3.53M
3.53M
2.44M
2.44M
Total operating expenses
3.53M
3.53M
2.44M
2.44M
Operating income
-3.53M
-3.53M
-2.44M
-2.44M
Other non operating income
178.57M
178.57M
-
-
EBT including unusual items
169.98M
169.98M
-4.86M
-4.86M
EBT excluding unusual items
169.98M
169.98M
-4.86M
-4.86M
Income tax expense
29.50K
29.50K
-134.00K
-134.00K
Effective tax rate
0.02%
0.02%
2.76%
2.76%
Other operating expenses
-
-
82.50K
82.50K
Net income
169.95M
169.95M
-4.73M
-4.73M
Net profit margin
33,990,400.00%
33,990,400.00%
-
-
Earnings per share
-
-
-
-
Interest and investment income
312.00K
312.00K
210.00K
210.00K
Interest expense
-5.53M
-5.53M
-
-
Net interest expenses
-5.22M
-5.22M
210.00K
210.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.53M
-3.53M
-2.44M
-2.44M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps